Scarica l'app Stockscreener
11.57
4.80%
0.53
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Vir Biotechnology Inc Borsa (VIR) Ultime notizie
BlackRock reports voting power over 20.6M shares in Vir Biotechnology (VIR). - Stock Titan
Vir Biotechnology (NASDAQ:VIR) Breaks Higher: Real Momentum? - Kalkine Media
Can Gilead's Deal With VIR Boost Its Oncology Pipeline and Growth? - Zacks Investment Research
Vir Biotechnology Sells 1.76 Million Shares to Gilead in $25M Stock Deal - Kalkine Media
VIR 8-K & SEC Filings - Yahoo! Finance Canada
Vir Biotechnology (VIR) Slides 4.25% to $10.82 as Support at $10.28 Comes Into FocusBPI Bear Confirmed - dars.gov.et
Vir Biotechnology (VIR) Slides 4.25% to $10.82 as Support at $10.28 Comes Into FocusSpring Pattern - dars.gov.et
Vir Biotechnology (VIR) Slides 4.25% to $10.82 as Support at $10.28 Comes Into FocusETF AUM Growth - https://www.siam.in/
Can Vir Biotechnology (NASDAQ:VIR) Keep Climbing After Latest Target Boost? - Kalkine Media
Aziz Sawaf, CFO of Vir Biotechnology (VIR), reports zero directly held common shares. - Stock Titan
One talk will cover hepatitis D response data through 96 weeks; another will study liver immune cells. - Stock Titan
A $150K sign-on bonus, contingent on continued employment, awaits Vir Biotechnology (VIR)'s incoming CFO. - Stock Titan
Vir Biotechnology, Inc. (NASDAQ:VIR) Stock Rated "Moderate Buy" by Sell-Side Brokerages - MarketBeat
Vir Biotechnology (NASDAQ:VIR) Nears Key Hepatitis Delta Readout - kalkinemedia.com
Vir Biotechnology (NasdaqGS:VIR) Stock Forecast & Analyst Predictions - Simply Wall Street
Vir Biotechnology Stock Price Forecast. Should You Buy VIR? - StockInvest.us
Engineers Gate Manager LP Sells 121,964 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat
Former Vir (NASDAQ: VIR) officer sold $315K in stock, with more share sales planned - Stock Titan
WINTON GROUP Ltd Trims Stake in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology (VIR) ex-officer to sell 28,333 shares from option exercise - Stock Titan
How (VIR) Movements Inform Risk Allocation Models - Stock Traders Daily
Legal & General Group Plc Invests $2.76 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Bank of New York Mellon Corp Makes New $7.08 Million Investment in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology stock gains on conference catalyst - ad-hoc-news.de
Man Group plc Takes $1.54 Million Position in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology stock gains on new 52-week high and conference appearance - ad-hoc-news.de
Corient Private Wealth LP Invests $3.17 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology (NASDAQ:VIR) Sets New 52-Week HighShould You Buy? - MarketBeat
Vir Biotechnology stock gains on conference participation and 52-week high - ad-hoc-news.de
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com South Africa
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com Canada
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com India
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com Nigeria
Vir Biotechnology stock hits 52-week high at 11.66 USD - investing.com
Vir Biotechnology stock hits 52-week high at 11.66 USD By Investing.com - Investing.com UK
Vir Biotechnology (NASDAQ:VIR) Trading 4.8% HigherHere's What Happened - MarketBeat
Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
Vir Biotechnology CEO to speak at Morgan Stanley conference Sept. 14 - Stock Titan
Deutsche Bank AG Acquires Shares of 134,258 Vir Biotechnology, Inc. $VIR - MarketBeat
ARCH Venture Management LLC Invests $129.35 Million in Vir Biotechnology, Inc. $VIR - MarketBeat
Algert Global LLC Purchases 315,969 Shares of Vir Biotechnology, Inc. $VIR - MarketBeat
ADAR1 Capital Management LLC Acquires New Shares in Vir Biotechnology, Inc. $VIR - MarketBeat
Vir Biotechnology (NASDAQ: VIR) ex-officer lines up more sales - Stock Titan
Vir Biotechnology (NASDAQ:VIR) Shares Up 8.1%Time to Buy? - MarketBeat
Vir Biotechnology (NASDAQ: VIR) officer plans 14,352-share sale after 25K sale - Stock Titan
Vir Biotechnology (NASDAQ: VIR) ex-officer files notice for potential $245K stock sale - Stock Titan
Vir Biotechnology on Track for Record Winning Streak -- Data Talk - Bitget
Vir (VIR) Close and Levels: Adds 1.06% to Close at $9.49 in the Latest Reading; Key Levels: the $9.02 to $9.96 Range Remains in Focus in Latest TradingRevenue Weighted - vinanet.vn
The Bull Case For Vir Biotechnology (VIR) Could Change Following A Sudden Swing To Quarterly Profitability - Sahm
0.23%
1.80%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):